Anna Przybyla
Overview
Explore the profile of Anna Przybyla including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
120
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kolenda T, Guglas K, Stasiak M, Poter P, Kozlowska-Maslon J, Bialas P, et al.
EXCLI J
. 2025 Jan;
23:1375-1396.
PMID: 39764216
Cutaneous melanoma is the deadliest form of skin cancer. Despite advancements in treatment, many patients still face poor outcomes. A deeper understanding of the mechanisms involved in melanoma pathogenesis is...
2.
Kazimierczak U, Przybyla A, Smielowska M, Kolenda T, Mackiewicz A
Cells
. 2024 Jun;
13(12.
PMID: 38920690
Melanoma is the most aggressive form of skin cancer. In the advanced stage of development, it is resistant to currently available therapeutic modalities. Increased invasiveness and metastatic potential depend on...
3.
Vasalou C, Proia T, Kazlauskas L, Przybyla A, Sung M, Mamidi S, et al.
CPT Pharmacometrics Syst Pharmacol
. 2024 Mar;
13(6):994-1005.
PMID: 38532525
Trastuzumab deruxtecan (T-DXd; DS-8201; ENHERTU®) is a human epithelial growth factor receptor 2 (HER2)-directed antibody drug conjugate (ADC) with demonstrated antitumor activity against a range of tumor types. Aiming to...
4.
Wang J, Yu W, DAnna R, Przybyla A, Wilson M, Sung M, et al.
Mol Cell Proteomics
. 2023 Jul;
22(9):100626.
PMID: 37517589
The National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium (CPTAC) provides unique opportunities for cancer target discovery using protein expression. Proteomics data from CPTAC tumor types have been primarily generated...
5.
Labedz W, Przybyla A, Zimna A, Dabrowski M, Kubaszewski L
Int J Mol Sci
. 2023 Feb;
24(4).
PMID: 36835198
Although many studies have investigated the role of cytokines in bone metastases, our knowledge of their function in spine metastasis is limited. Therefore, we performed a systematic review to map...
6.
Przybyla A, Lehmann A, Zhang T, Mackiewicz J, Galus L, Kirchenbaum G, et al.
Cancers (Basel)
. 2021 Jan;
13(2).
PMID: 33435427
Healthy human subjects develop spontaneous CD8+ T cell responses to melanoma associated antigens (MA) expressed by normal melanocytes, such as Tyrosinase, MAGE-A3, Melan/Mart-1, gp100, and NY-ESO-1. This natural autoimmunity directed...
7.
Sobocinska J, Kolenda T, Teresiak A, Badziag-Lesniak N, Kopczynska M, Guglas K, et al.
Diagnostics (Basel)
. 2020 Oct;
10(10).
PMID: 33027913
Lynch syndrome (LS), also known as hereditary nonpolyposis colorectal cancer (HNPCC), is a disorder caused by an autosomal dominant heterozygous germline mutation in one of the DNA mismatch repair (MMR)...
8.
Przybyla A, Czarnecka D
Postepy Kardiol Interwencyjnej
. 2019 Oct;
15(3):357-363.
PMID: 31592167
Introduction: Cardiac resynchronization therapy (CRT) was a breakthrough in the treatment of heart failure, but data regarding the effect of this therapy on numerous disorders associated with heart failure are...
9.
Przybyla A, Zhang T, Li R, Roen D, Mackiewicz A, Lehmann P
Cancer Immunol Immunother
. 2019 Feb;
68(5):709-720.
PMID: 30783693
We used four-color ImmunoSpot® assays, in conjunction with peptide pools that cover the sequence of tyrosinase (Tyr), melanoma-associated antigen A3 (MAGE-A3), melanocyte antigen/melanoma antigen recognized by T cells 1 (Melan-A/MART-1),...
10.
Kwiatkowska-Borowczyk E, Czerwinska P, Mackiewicz J, Gryska K, Kazimierczak U, Tomela K, et al.
Oncoimmunology
. 2018 Nov;
7(11):e1509821.
PMID: 30377573
Allogeneic whole cell gene modified therapeutic melanoma vaccine (AGI-101H) comprising of two melanoma cell lines transduced with cDNA encoding fusion protein composed of IL-6 linked with the soluble IL-6 receptor...